Skip to main content

Care

By Jessica Hagen | 08:18 pm | June 02, 2023
In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer the discounted Humira alternative.
By Jessica Hagen | 01:00 pm | June 02, 2023
The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.
HIMSS23
By HIMSS TV | 01:00 pm | June 02, 2023
Gita Barry, president of immersive healthcare at Penumbra, discusses the uses of immersive VR technology for therapy in healthcare settings and at home, and its potential to engage patients and employees.
By Jessica Hagen | 12:27 pm | June 02, 2023
Sigurjon Kristjansson, CEO of Nox Health, tells MobiHealthNews why his company made the largest bid for Pear Therapeutics' assets at a recent bankruptcy auction
HIMSS23
By HIMSS TV | 07:00 am | June 02, 2023
Dr. Lyle Berkowitz, CEO of KeyCare, talks about how virtual providers free up clinicians' time by handling "triple R" – routine, repeatable and rules-based – care visits that can occupy more than 50% of a physician's day.
By Jessica Hagen | 02:42 pm | June 01, 2023
Transcarent is led by digital health investor, entrepreneur and Livongo vet Glen Tullman. U.S. tennis champion Andy Roddick cofounded ViewFi.
By Jessica Hagen | 11:41 am | June 01, 2023
The company will use the funds to support and grow its team, enhance its platform and expand partnerships with payors, health systems and physicians.
By Jessica Hagen | 12:35 pm | May 31, 2023
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
HIMSS23
By HIMSS TV | 07:00 am | May 31, 2023
Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.
By Jessica Hagen | 03:07 pm | May 30, 2023
The California-based company will use the funds to expand its oncology and surgical care-focused offerings.